Kutatási jelek – Signal Engine

• Consensus statement on the multidisciplinary treatment of nasopharyngeal carcinoma with immune checkpoint inhibitors in China — Nasopharyngeal carcinoma
• Neoadjuvant systemic therapy for pleural mesothelioma patients: a systematic review — Malignant pleural mesothelioma
• Cryoablation plus sintilimab and lenvatinib in advanced or metastatic intrahepatic cholangiocarcinoma: a phase 2 trial — Cholangiocarcinoma
• T-cell acute lymphoblastic leukemia: therapeutic outcomes in adolescents and young adults — Acute lymphoblastic leukemia
• PD-1/PD-L1 inhibitors for locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis based on randomized controlled trials — Nasopharyngeal carcinoma
• The treatment and prognosis of pediatric adrenocortical carcinoma — Adrenocortical carcinoma
• A case report of cytoreductive surgery of metastatic adrenal cancer in a patient with tumor progression — Gastrointestinal stromal tumor
• The therapeutic perspective of relapsed/refractory Waldenström Macroglobulinemia: what comes next? — Waldenstrom macroglobulinemia
• Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): a phase 2 clinical trial — Head and neck squamous cell carcinoma
• Montelukast as a novel therapeutic approach in metastatic uveal melanoma harboring a CYSLTR2 mutation: a translational case report — Melanoma
• Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial — Nasopharyngeal carcinoma
• State-of-the-Art Review: Cardiovascular Disease in Patients With Chronic Myeloid Leukemia — Chronic myeloid leukemia
• Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient‑centered perspective — Chronic myeloid leukemia
• Changing landscape of advanced esophageal squamous cell carcinoma: Breakthroughs in systemic therapies (Review) — Esophageal cancer
• Neoadjuvant immunotherapy in squamous cell carcinoma of the head and neck: current evidence and future perspectives — Head and neck squamous cell carcinoma
• Multi-omics-based molecular classification of adrenocortical carcinoma predicts response to immunotherapy and targeted treatments — Adrenocortical carcinoma
• Impact of steroid differentiation on tumor microenvironment revealed by single-nucleus atlas of adrenal tumors — Adrenocortical carcinoma
• Targeting pediatric adrenocortical carcinoma: Molecular insights and emerging therapeutic strategies — Adrenocortical carcinoma
• Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice — Chronic lymphocytic leukemia
• Biological features of squamous cell carcinoma of the anus— a deep dive review — Anal squamous cell carcinoma